| Identification | Back Directory | [Name]
Benzamide, 3-[(1S)-2-methoxy-1-methylethoxy]-5-[4-(methylsulfonyl)phenoxy]-N-(3-methyl-1,2,4-thiadiazol-5-yl)- | [CAS]
863504-35-2 | [Synonyms]
GKA71
GKA-71
GKA 71
Benzamide, 3-[(1S)-2-methoxy-1-methylethoxy]-5-[4-(methylsulfonyl)phenoxy]-N-(3-methyl-1,2,4-thiadiazol-5-yl)- | [Molecular Formula]
C21H23N3O6S2 | [MDL Number]
MFCD28160542 | [MOL File]
863504-35-2.mol | [Molecular Weight]
477.55 |
| Hazard Information | Back Directory | [Description]
GKA-71 is a potent glucokinase activator (GKA). | [Uses]
GKA-71 is an orally active Glucokinase activator, possesses an islet protective effect[1]. | [References]
[1] Maria S?rhede Winzell, et al. Chronic glucokinase activation reduces glycaemia and improves glucose tolerance in high-fat diet fed mice. Eur J Pharmacol. 2011 Aug 1;663(1-3):80-6. DOI:10.1016/j.ejphar.2011.05.009 |
|
|